Selection for virulent dengue viruses occurs in humans and mosquitoes

Journal of Virology

Volumn 79, Issue 2, 2005, Pages 853-859

  Cologna, Raymond ^a   Armstrong, Philip M ^a   Rico Hesse, Rebeca ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEDES AEGYPTI; ANTIGENICITY; ARTICLE; DENDRITIC CELL; DENGUE VIRUS; EPIDEMIC; GENOTYPE; MOSQUITO; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; VECTOR CONTROL; VIREMIA; VIRUS INFECTION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AEDES; ANIMALS; DENGUE VIRUS; FEMALE; GENOTYPE; HUMANS; PHYLOGENY; VIRULENCE; VIRUS REPLICATION;

EID: 11144246888     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.2.853-859.2005     Document Type: Article

References (32)

1. Armstrong, P. M., and R. Rico-Hesse. 2001. Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis. 1:159-168.
2. Armstrong, P. M., and R. Rico-Hesse. 2003. Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am. J. Trop. Med. Hyg. 68:539-544.
3. Cologna, R., and R. Rico-Hesse. 2003. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77:3929-3938.
4. Cooper, V. S., M. H. Reiskind, J. A. Miller, K. A. Shelton, B. A. Walther, J. S. Elkinton, and P. W. Ewald. 2002. Timing of transmission and the evolution of virulence of an insect virus. Proc. R. Soc. Lond. B 269:1161-1165.
5. Elena, S. F., and R. Sanjuan. 2003. Evolution. Climb every mountain? Science 302:2074-2075.
6. Failloux, A. B., M. Vazeille, and F. Rodhain. 2002. Geographic genetic variation in populations of the dengue virus vector Aedes aegypti. J. Mol. Evol. 55:653-663.
7. Gubler, D. J., S. Nalim, R. Tan, H. Saipan, and J. Sulianti Saroso. 1979. Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti. Am. J. Trop. Med. Hyg. 28:1045-1052.
8. Gubler, D. J., D. Reed, L. Rosen, and J. R. Hitchcock, Jr. 1978. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27:581-589.
9. Gubler, D. J., W. Suharyono, I. Lubis, S. Eram, and S. Gunarso. 1981. Epidemic dengue 3 in central Java, associated with low viremia in man. Am. J. Trop. Med. Hyg. 30:1094-1099.
10. Halstead, S. B. 2003. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60:421-467.
11. Halstead, S. B. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J. Biol. Med. 42:350-362.
12. Halstead, S. B., and J. Deen. 2002. The future of dengue vaccines. Lancet 360:1243-1245.
13. Kuberski, T. T., and L. Rosen. 1977. A simple technique for the detection of dengue antigen in mosquitoes by immunofluorescence. Am. J. Trop. Med. Hyg. 26:533-537.
14. Leitmeyer, K. C., D. W. Vaughn, D. M. Watts, R. Salas, I. Villalobos de Chacon, C. Ramos, and R. Rico-Hesse. 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:4738-4747.
15. Libraty, D. H., T. P. Endy, H. S. Houng, S. Green, S. Kalayanarooj, S. Suntayakorn, W. Chansiriwongs, D. W. Vaughn, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J. Infect. Dis. 185:1213-1221.
16. Libraty, D. H., S. Pichyangkul, C. Ajariyakhajorn, T. P. Endy, and F. A. Ennis. 2001. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75:3501-3508.
17. Messer, W. B., D. J. Gubler, E. Harris, K. Sivananthan, and A. M. de Silva. 2003. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg. Infect. Dis. 9:800-809.
18. Messer, W. B., U. T. Vitarana, K. Sivananthan, J. Elvtigala, L. D. Preethimala, R. Ramesh, N. Withana, D. J. Gubler, and A. M. De Silva. 2002. Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 66:765-773.
19. Murgue, B., C. Roche, E. Chungue, and X. Deparis. 2000. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J. Med. Virol. 60:432-438.
20. Rico-Hesse, R. 2003. Microevolution and virulence of dengue viruses. Adv. Virus Res. 59:315-341.
21. Rico-Hesse, R. 1990. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174:479-493.
22. Rico-Hesse, R., L. M. Harrison, R. A. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M. T. de Mesa, R. M. Nogueira, and A. T. da Rosa. 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244-251.
23. Rosen, L. 1977. The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 26:337-343.
24. Rothman, A. L. 2003. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 60:397-419.
25. Rothman, A. L., and F. A. Ennis. 1999. Immunopathogenesis of Dengue hemorrhagic fever. Virology 257:1-6.
26. Swofford, D. 2002. PAUP*, phylogenetic analysis using parsimony (*and other methods), version 4.0b10. Sinauer Associates, Sunderland, Mass.
27. Uzcategui, N. Y., G. Comach, D. Camacho, M. Salcedo, M. Cabello de Quintana, M. Jimenez, G. Sierra, R. Cuello de Uzcategui, W. S. James, S. Turner, E. C. Holmes, and E. A. Gould. 2003. Molecular epidemiology of dengue virus type 3 in Venezuela. J. Gen. Virol. 84:1569-1575.
28. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, and A. Nisalak. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2-9.
29. Wang, W. K., D. Y. Chao, C. L. Kao, H. C. Wu, Y. C. Liu, C. M. Li, S. C. Lin, S. T. Ho, J. H. Huang, and C. C. King. 2003. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 305:330-338.
30. Watts, D. M., K. R. Porter, P. Putvatana, B. Vasquez, C. Calampa, C. G. Haves, and S. B. Halstead. 1999. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 354:1431-1434.
31. World Health Organization. 2004, posting date. Dengue/dengue haemorrhagic fever. [Online.] http://www.who.int/csr/disease/dengue/en/.
32. Wu, S. J., G. Grouard-Vogel, W. Sun, J. R. Mascola, E. Brachtel, R. Putvatana, M. K. Louder, L. Filgueira, M. A. Marovich, H. K. Wong, A. Blauvelt, G. S. Murphy, M. L. Robb, B. L. Innes, D. L. Birx, C. G. Hayes, and S. S. Frankel. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820.